Rapid Nexus earns FDA clearance for first wound healing device California med-tech firm Rapid Nexus secures FDA clearance for Hemastyl, a device targeting the root cause of chronic non-healing wounds.

Rapid Nexus secures FDA clearance for Hemastyl, the first device targeting periwound tissue to improve chronic wound healing and reduce amputations. A major step forward in advanced wound care innovation.
#News #FDAclearance #MedTech #WoundCare #HealthcareInnovation #RapidNexus

Rapid Nexus earns FDA clearance for first wound healing device California med-tech firm Rapid Nexus secures FDA clearance for Hemastyl, a device targeting the root cause of chronic non-healing wounds.

Rapid Nexus secures FDA clearance for Hemastyl, the first device targeting periwound tissue to improve chronic wound healing and reduce amputations. A major step forward in advanced wound care innovation.
#News #FDAclearance #MedTech #WoundCare #HealthcareInnovation #RapidNexus